Company’s lowest close in a decade

  • Illumina’s stock fell 14% and is on track for its lowest close in 10 years
  • The company cut its full-year sales and profit guidance
  • Illumina missed revenue estimates for the third quarter
  • The stock has fallen for four of the past five days and is down three straight days
  • It has fallen 54% in the year to date

Illumina Inc.’s stock fell 14% on Friday, putting it on track for its lowest close in 10 years. The maker of DNA-sequencing technology cut its full-year sales and profit guidance after missing revenue estimates for the third quarter. The stock has fallen for four of the past five days and is down three straight days. It has fallen 54% in the year to date, marking a significant decline for the company.

Factuality Level: 8
Factuality Justification: The article provides factual information about Illumina Inc.’s stock performance, including its decline, the reasons for the decline, and the comparison to previous trading periods. The information is supported by data from Dow Jones Market Data. However, the article does not provide any analysis or context beyond the stock performance.
Noise Level: 3
Noise Justification: The article provides relevant information about Illumina Inc.’s stock performance, including its recent decline and the reasons behind it. It also compares the stock’s performance to the broader market. However, the article lacks in-depth analysis, scientific rigor, and actionable insights. It mainly focuses on reporting the stock’s price movements and does not provide a comprehensive understanding of the company’s long-term trends or antifragility.
Financial Relevance: Yes
Financial Markets Impacted: The stock market and Illumina Inc.
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Rating Justification: The article pertains to financial topics as it discusses the stock performance of Illumina Inc. The company’s stock has fallen significantly, reaching its lowest close in 10 years, after the company cut its full-year sales and profit guidance and missed revenue estimates for the third quarter. However, there is no mention of an extreme event or its impact.
Public Companies: Illumina Inc. (ILMN), S&P 500 (SPX)
Key People:


Reported publicly: www.marketwatch.com